Empagliflozin has kidney protective effects and reduces heart failure outcomes across baseline kidney function among patients ...

Liberal blood transfusion after heart attack in patients with kidney disease (CKD) is not harmful, according to study results.

Patients with history of preeclampsia have increased risk for myocardial infarction and worse myocardial infarction outcomes.

U.S. heart disease mortality has dropped 66% since 1970, mainly due to fewer ischemic heart disease deaths. However, deaths ...

Acute MI mortality has fallen, yet deaths from other diseases, including heart failure and hypertension, are on the rise.

Forensics specialist Emmanuel Margueritte, MD, explains when physicians must flag a death for judicial review under France’s ...

A new study highlights a sharp decline in deaths from heart attacks, while showing a significant rise in mortality from other heart conditions.

New data highlight a substantial decline in overall heart disease death rates during the past 50 years, along with a shift in ...

For patients with T2D, semaglutide seems to confer some advantage over empagliflozin in terms of mortality and CV event risks.

In an early look at SCOT-HEART 2, CCTA led more primary-prevention patients to make changes to reduce their risk of CVD.

After suffering from acute myocardial infarction, the mortality rate of local health insurance subscribers was higher than that of working subscribers. A joint research team led by Professor Kang ...